These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 37807731)

  • 1. [Risk modeling based on HER-2 related genes for bladder cancer survival prognosis assessment].
    Liu HR; Peng X; Li SL; Gou X
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Oct; 55(5):793-801. PubMed ID: 37807731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction of prognostic risk model of bladder cancer based on cuproptosis-related long non-coding RNAs.
    Xu C; Chen A; Mao C; Cui B
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2023 Apr; 52(2):139-147. PubMed ID: 37283097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
    Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
    BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction of a prediction model for prognosis of bladder cancer based on the expression of ion channel-related genes.
    Zhang D; Yin G; Zheng S; Chen Q; Li Y
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2023 Aug; 52(4):499-509. PubMed ID: 37643983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive
    Xu T; Xu W; Zheng Y; Li X; Cai H; Xu Z; Zou Q; Yu B
    Front Immunol; 2022; 13():931906. PubMed ID: 35958598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Classification of bladder cancer based on immune cell infiltration and construction of a risk prediction model for prognosis.
    Yin G; Zheng S; Zhang W; Dong X; Qi L; Li Y
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2023 Dec; 53(1):47-57. PubMed ID: 38229504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction and validation of a bladder cancer risk model based on autophagy-related genes.
    Shen C; Yan Y; Yang S; Wang Z; Wu Z; Li Z; Zhang Z; Lin Y; Li P; Hu H
    Funct Integr Genomics; 2023 Jan; 23(1):46. PubMed ID: 36689018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction and verification of a prognostic risk model based on immunogenomic landscape analysis of bladder caner.
    Zhang Y; Xie Y; Feng Y; Wang Y; Xu X; Zhu S; Xu F; Feng N
    Gene; 2022 Jan; 808():145966. PubMed ID: 34530089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A robust signature of immune-related long non-coding RNA to predict the prognosis of bladder cancer.
    Lai C; Wu Z; Li Z; Yu H; Li K; Tang Z; Liu C; Xu K
    Cancer Med; 2021 Sep; 10(18):6534-6545. PubMed ID: 34374227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bladder cancer survival nomogram: Development and validation of a prediction tool, using the SEER and TCGA databases.
    Zhang Y; Hong YK; Zhuang DW; He XJ; Lin ME
    Medicine (Baltimore); 2019 Nov; 98(44):e17725. PubMed ID: 31689813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IGF2BP3 overexpression predicts poor prognosis and correlates with immune infiltration in bladder cancer.
    Huang W; Zhu L; Huang H; Li Y; Wang G; Zhang C
    BMC Cancer; 2023 Feb; 23(1):116. PubMed ID: 36732736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Hypoxia-Related Subtypes, Establishment of Prognostic Models, and Characteristics of Tumor Microenvironment Infiltration in Colon Cancer.
    Wang C; Tang Y; Ma H; Wei S; Hu X; Zhao L; Wang G
    Front Genet; 2022; 13():919389. PubMed ID: 35783281
    [No Abstract]   [Full Text] [Related]  

  • 13. Bioinformatics analysis of prognosis and immune microenvironment of immunological cell death-related gemcitabine-resistance genes in bladder cancer.
    Liu C; Wang XL; Shen EC; Wang BZ; Meng R; Cui Y; Wang WJ; Shao Q
    Transl Androl Urol; 2022 Dec; 11(12):1715-1728. PubMed ID: 36632166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Derivation and Comprehensive Analysis of Aging Patterns in Patients with Bladder Cancer.
    Wang B; Tong F; Zhai C; Wang L; Liu Y; Wang J
    Dis Markers; 2021; 2021():3385058. PubMed ID: 34721733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognosis analysis and validation of lipid metabolism-associated lncRNAs and tumor immune microenvironment in bladder cancer.
    Tan Z; Fu S; Zuo J; Wang J; Wang H
    Aging (Albany NY); 2023 Aug; 15(16):8384-8407. PubMed ID: 37632832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Normal tissue adjacent to tumor expression profile analysis developed and validated a prognostic model based on Hippo-related genes in hepatocellular carcinoma.
    Pan Q; Qin F; Yuan H; He B; Yang N; Zhang Y; Ren H; Zeng Y
    Cancer Med; 2021 May; 10(9):3139-3152. PubMed ID: 33818013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The construction and validation of an RNA binding protein-related prognostic model for bladder cancer.
    Chen F; Wang Q; Zhou Y
    BMC Cancer; 2021 Mar; 21(1):244. PubMed ID: 33685397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a novel defined inflammation-related long noncoding RNA signature contributes to predicting prognosis and distinction between the cold and hot tumors in bladder cancer.
    Xiong X; Chen C; Li X; Yang J; Zhang W; Wang X; Zhang H; Peng M; Li L; Luo P
    Front Oncol; 2023; 13():972558. PubMed ID: 37064115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel survival model based on a Ferroptosis-related gene signature for predicting overall survival in bladder cancer.
    Liang Y; Ye F; Xu C; Zou L; Hu Y; Hu J; Jiang H
    BMC Cancer; 2021 Aug; 21(1):943. PubMed ID: 34418989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of immune-related genes as prognostic factors in bladder cancer.
    Zhu J; Wang H; Ma T; He Y; Shen M; Song W; Wang JJ; Shi JP; Wu MY; Liu C; Wang WJ; Huang YQ
    Sci Rep; 2020 Nov; 10(1):19695. PubMed ID: 33184436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.